Trade Summary

3 days ago, Garland Jason K, serving as CFO at REPLIGEN CORP (RGEN), sold 733 shares at $145.00 per share, for a total transaction value of $106,285.00. Following this transaction, Garland Jason K now holds 19,359 shares of RGEN.

This sale represents a 3.65% decrease in Garland Jason K's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, June 25, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 26, 2026 at 4:05 PM ET, 1 day after the trade was made.

REPLIGEN CORP operates in the HEALTHCARE sector, specifically within the MEDICAL INSTRUMENTS & SUPPLIES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.